284 related articles for article (PubMed ID: 1311847)
1. Evidence for a membrane defect in Alzheimer disease brain.
Nitsch RM; Blusztajn JK; Pittas AG; Slack BE; Growdon JH; Wurtman RJ
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1671-5. PubMed ID: 1311847
[TBL] [Abstract][Full Text] [Related]
2. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease.
Nitsch R; Pittas A; Blusztajn JK; Slack BE; Growdon JH; Wurtman RJ
Ann N Y Acad Sci; 1991; 640():110-3. PubMed ID: 1663712
[TBL] [Abstract][Full Text] [Related]
3. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
Blusztajn JK; Lopez Gonzalez-Coviella I; Logue M; Growdon JH; Wurtman RJ
Brain Res; 1990 Dec; 536(1-2):240-4. PubMed ID: 2150771
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity.
Ross BM; Moszczynska A; Erlich J; Kish SJ
J Neurochem; 1998 Feb; 70(2):786-93. PubMed ID: 9453575
[TBL] [Abstract][Full Text] [Related]
5. Alterations of selected enzymes of phospholipid metabolism in Alzheimer's disease brain tissue as compared to non-Alzheimer's demented controls.
Kanfer JN; Pettegrew JW; Moossy J; McCartney DG
Neurochem Res; 1993 Mar; 18(3):331-4. PubMed ID: 8386814
[TBL] [Abstract][Full Text] [Related]
6. Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients.
Walter A; Korth U; Hilgert M; Hartmann J; Weichel O; Hilgert M; Fassbender K; Schmitt A; Klein J
Neurobiol Aging; 2004; 25(10):1299-303. PubMed ID: 15465626
[TBL] [Abstract][Full Text] [Related]
7. Effects of ethanolamine (Etn) administration on Etn and choline (Ch) levels in plasma, brain extracellular fluid (ECF) and brain tissue, and on brain phospholipid levels in rats: an in vivo study.
Marshall DL; De Micheli E; Bogdanov MB; Wurtman RJ
Neurosci Res Commun; 1996; 18(2):87-96. PubMed ID: 11540106
[TBL] [Abstract][Full Text] [Related]
8. The hydrolysis of glycerophosphocholine by rat brain microsomes: activation and inhibition.
Spanner S; Ansell GB
Neurochem Res; 1987 Feb; 12(2):203-6. PubMed ID: 3033533
[TBL] [Abstract][Full Text] [Related]
9. Glycerophosphocholine-dependent growth requires Gde1p (YPL110c) and Git1p in Saccharomyces cerevisiae.
Fisher E; Almaguer C; Holic R; Griac P; Patton-Vogt J
J Biol Chem; 2005 Oct; 280(43):36110-7. PubMed ID: 16141200
[TBL] [Abstract][Full Text] [Related]
10. Insulin stimulates turnover of phosphatidylcholine in rat adipocytes.
Macaulay SL; Larkins RG
Mol Cell Biochem; 1994 Jul; 136(1):23-8. PubMed ID: 7854328
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy.
Nitsch RM; Blusztajn JK; Doyle FM; Robitaille Y; Wurtman RJ; Growdon JH; Kish SJ
Neurosci Lett; 1993 Oct; 161(2):191-4. PubMed ID: 8272265
[TBL] [Abstract][Full Text] [Related]
12. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia.
Puri BK
Int Rev Psychiatry; 2006 Apr; 18(2):145-7. PubMed ID: 16777668
[TBL] [Abstract][Full Text] [Related]
13. Neural membrane phospholipids in Alzheimer disease.
Wells K; Farooqui AA; Liss L; Horrocks LA
Neurochem Res; 1995 Nov; 20(11):1329-33. PubMed ID: 8786819
[TBL] [Abstract][Full Text] [Related]
14. Glycerophosphorylcholine phosphocholine phosphodiesterase activity of rat brain myelin.
Kanfer JN; McCartney DG
J Neurosci Res; 1989 Oct; 24(2):231-40. PubMed ID: 2555532
[TBL] [Abstract][Full Text] [Related]
15. Glycerophosphocholine and phosphocholine are the major choline metabolites in rat milk.
Rohlfs EM; Garner SC; Mar MH; Zeisel SH
J Nutr; 1993 Oct; 123(10):1762-8. PubMed ID: 8410369
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of glycerophosphocholine (GPC) by renal cells: osmotic regulation of GPC:choline phosphodiesterase.
Zablocki K; Miller SP; Garcia-Perez A; Burg MB
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7820-4. PubMed ID: 1652765
[TBL] [Abstract][Full Text] [Related]
17. Breakdown of membrane phospholipids in Alzheimer disease. Involvement of excitatory amino acid receptors.
Farooqui AA; Wells K; Horrocks LA
Mol Chem Neuropathol; 1995; 25(2-3):155-73. PubMed ID: 8534318
[TBL] [Abstract][Full Text] [Related]
18. Multiple forms of the enzyme glycerophosphodiesterase are present in human brain.
Ross BM; Sherwin AL; Kish SJ
Lipids; 1995 Dec; 30(12):1075-81. PubMed ID: 8614297
[TBL] [Abstract][Full Text] [Related]
19. Glycerophosphocholine metabolism in higher plant cells. Evidence of a new glyceryl-phosphodiester phosphodiesterase.
van der Rest B; Boisson AM; Gout E; Bligny R; Douce R
Plant Physiol; 2002 Sep; 130(1):244-55. PubMed ID: 12226504
[TBL] [Abstract][Full Text] [Related]
20. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
